Kingsview Wealth Management LLC Boosts Stock Position in Select Medical Holdings Co. (NYSE:SEM)

Kingsview Wealth Management LLC raised its holdings in shares of Select Medical Holdings Co. (NYSE:SEM) by 92.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 106,623 shares of the health services provider’s stock after purchasing an additional 51,361 shares during the quarter. Kingsview Wealth Management LLC’s holdings in Select Medical were worth $2,010,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in SEM. Jennison Associates LLC lifted its holdings in shares of Select Medical by 542.7% in the 4th quarter. Jennison Associates LLC now owns 115,185 shares of the health services provider’s stock valued at $2,171,000 after acquiring an additional 97,264 shares during the last quarter. Financial Strategies Group Inc. lifted its stake in shares of Select Medical by 37.6% in the 4th quarter. Financial Strategies Group Inc. now owns 14,738 shares of the health services provider’s stock valued at $269,000 after purchasing an additional 4,029 shares during the last quarter. Sivik Global Healthcare LLC boosted its holdings in shares of Select Medical by 7.1% in the 4th quarter. Sivik Global Healthcare LLC now owns 150,000 shares of the health services provider’s stock worth $2,828,000 after purchasing an additional 10,000 shares during the period. Sippican Capital Advisors increased its position in shares of Select Medical by 7.3% during the 4th quarter. Sippican Capital Advisors now owns 13,354 shares of the health services provider’s stock valued at $252,000 after purchasing an additional 912 shares during the last quarter. Finally, KBC Group NV raised its holdings in Select Medical by 14.0% during the 4th quarter. KBC Group NV now owns 14,883 shares of the health services provider’s stock valued at $281,000 after buying an additional 1,833 shares during the period. 89.48% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th. Royal Bank of Canada upped their price target on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th. StockNews.com raised shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Monday, January 27th. Finally, UBS Group dropped their target price on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $39.50.

Select Medical Trading Down 0.4 %

NYSE SEM opened at $18.75 on Tuesday. Select Medical Holdings Co. has a 12 month low of $18.02 and a 12 month high of $40.98. The company’s 50-day moving average price is $19.37 and its 200-day moving average price is $29.18. The stock has a market cap of $2.43 billion, a PE ratio of 8.76, a PEG ratio of 0.65 and a beta of 1.45. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37.

Insiders Place Their Bets

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total transaction of $99,530.55. Following the transaction, the vice president now owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. This represents a 14.12 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the sale, the director now owns 22,000 shares of the company’s stock, valued at $463,980. The trade was a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 19.14% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.